Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Other solid neoplasm 1

Conditions

Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Advanced Solid Tumors 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × ascrinvacumab × Clear all
NCT02116894 2019-03-14

REGAL-1

Duke University

Phase 1 Completed
11 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01337050 2015-10-28

Asian Phase I Study Of PF-03446962

Pfizer

Phase 1 Completed
36 enrolled 24 charts
Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT00557856 2015-10-19

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

Pfizer

Phase 1 Completed
70 enrolled 22 charts
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡